about
Functional properties and genomics of glucose transportersA glucose sensor hiding in a family of transportersThioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetesIndicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitusRenal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of actionThe fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells.Update on the treatment of type 2 diabetes mellitusSodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A ReviewProximal nephronSLC2A9 is a high-capacity urate transporter in humansMouse SGLT3a generates proton-activated currents but does not transport sugarScaling and systems biology for integrating multiple organs-on-a-chip.Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.The mechanism of photo-energy storage in the Halorhodopsin chloride pump.Rat kidney MAP17 induces cotransport of Na-mannose and Na-glucose in Xenopus laevis oocytes.Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparAddition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 TrialCadmium down-regulation of kidney Sp1 binding to mouse SGLT1 and SGLT2 gene promoters: possible reaction of cadmium with the zinc finger domain of Sp1Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.A fluorescence method for measurement of glucose transport in kidney cellsCurrent therapies and emerging drugs in the pipeline for type 2 diabetes.Functional characterization of a Na(+)-coupled dicarboxylate carrier protein from Staphylococcus aureusTubular reabsorption and diabetes-induced glomerular hyperfiltration.Employing Escherichia coli to functionally express, purify, and characterize a human transporterPharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.A Review on the Relationship between SGLT2 Inhibitors and Cancer.SGLT-2 inhibitors in development for type 2 diabetes treatmentCanagliflozin: a novel treatment option for type 2 diabetes.Alternative splicing and diversity of renal transporters.Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitusFunctional expression of SGLTs in rat brainSGLT2 mediates glucose reabsorption in the early proximal tubule.Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.Dapagliflozin efficacy and safety: a perspective review.Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?Dapagliflozin for the treatment of type 2 diabetes: a review of the literatureSodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology.Chronic sodium-retaining action of insulin in diabetic dogs
P2860
Q24651540-FD376F06-8926-435D-8280-810EAFA32398Q24672895-F65C0C39-E6E3-4CEE-892C-A2E6C6EBC20AQ24684670-8BDE3A2C-E861-43F9-959D-CA5B553E10A6Q26799252-6611F66B-C236-4787-9498-E3D371868901Q27027105-29EE51F4-F6EF-4047-BA60-FBCED2299AF0Q27316974-F3B93700-C0E4-41FD-ADB0-406F40D28593Q28073342-76210A2C-81D5-450F-B456-A28F8281FEE2Q28079134-17EF8A0C-3001-4730-87B1-5FD9EC9C04DFQ28388052-8AE4210A-3E7E-4DEC-A505-2448FFB82D41Q28473781-5349F93D-2E4F-4219-85CF-3B3CAA6FE047Q28508825-7570A037-F0FC-4F56-8D60-2BC43296DDA3Q30410626-B0C1C35D-54AD-44D5-8CF9-29F85E080860Q30429061-88F1545B-70CA-432C-905A-469B3C073367Q30487511-92423108-D115-4D92-8872-5A6930AF2C9DQ30948630-7BA879AA-48D9-4DC9-A1DB-0D60B36B30BBQ33612741-9C74786A-06FF-4E10-A046-52827162AEFBQ33614337-B3C35D84-1324-42D7-9AFB-20811D5C03E5Q33770941-79973FF1-5B02-419B-859D-0262BE07901DQ33837017-66D03B20-5D23-40CA-8043-B45A9DB5AE6EQ33878898-A8A55C72-3B89-4044-AA82-44D114D2DE46Q33928941-5DE742B6-6FA4-45AA-9415-0701D71660FAQ33937357-13D5279E-A6D0-42DB-A2D5-BD6F0F474457Q34057976-259DC5A5-1E05-46D2-B702-234CD4FC8861Q34065202-162BCFDA-F6BF-4622-9411-82238AD1D34FQ34105064-13BD0298-7B2C-4DB2-A09A-7209FC45B66EQ34120717-0935A352-EAD9-41CF-97CC-3169721922AFQ34181385-FA1E39D1-669B-4BA2-85E1-416B62857D2AQ34248505-50AA0B99-3951-4734-BFA9-2C8319396E01Q34388544-1C097BE6-712A-4772-A49C-C387AC11337FQ34396241-3A2473E0-55F5-4CFD-B913-4D5A43D9BFBCQ34407893-7DE6A737-F35B-49E6-9477-A2B7A8AB4E0CQ34426413-575E15C1-8864-413E-B282-434FCC0CA36EQ34457264-00B5C65F-C8B5-414F-B130-7AB4AF39E6A1Q34501684-CF5DDFB4-57C1-4D93-A1F8-9D77249E9EACQ34503796-92C1CFF3-5B52-4FD5-AE33-229A61C27410Q34514280-417AF818-675A-4674-B041-55F64F952BF6Q34579919-476E2539-87D0-434E-B800-793E9C99A502Q34710819-EA0E2032-0042-4321-AD8F-0FABF2C105A9Q34726437-1D6E9BF3-294E-467C-BAFA-FE3250A00A02Q34784142-A2F02F30-F8BE-478E-AC8B-B1DF48B08DE6
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Renal Na(+)-glucose cotransporters
@ast
Renal Na(+)-glucose cotransporters
@en
Renal Na(+)-glucose cotransporters
@nl
type
label
Renal Na(+)-glucose cotransporters
@ast
Renal Na(+)-glucose cotransporters
@en
Renal Na(+)-glucose cotransporters
@nl
prefLabel
Renal Na(+)-glucose cotransporters
@ast
Renal Na(+)-glucose cotransporters
@en
Renal Na(+)-glucose cotransporters
@nl
P2860
P921
P3181
P1476
Renal Na(+)-glucose cotransporters
@en
P2093
E M Wright
P2860
P3181
P356
10.1152/AJPRENAL.2001.280.1.F10
P407
P577
2001-01-01T00:00:00Z